NODE-NEGATIVE BREAST CANCER
Clinical trials for NODE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new NODE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for NODE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shot aims to stop early breast cancer from returning
Disease control OngoingThis Phase 2 trial is testing whether a combination of two targeted drugs (trastuzumab and pertuzumab) given as a single shot under the skin, along with standard hormone therapy, can prevent cancer from returning after surgery in people with early-stage, hormone receptor-positive…
Matched conditions: NODE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Hormone pills before surgery may improve breast cancer outcomes
Disease control OngoingThis study tests whether giving 6 months of hormone therapy before surgery helps remove all cancer cells in women with early-stage, estrogen-positive breast cancer. It involves 8 postmenopausal women with low-risk, node-negative tumors. The goal is to see if this approach leads t…
Matched conditions: NODE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Irada Ibrahim-zada • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC